Want to buy healthcare stocks, see what Edward Owens is buying. He is the manager of Vanguard Healthcare Fund since 1984, averaging more than 19% a year. These are his buys and sells during the first quarter. Edward Owens owns 81 stocks with a total value of $24.5 billion.
Edward Owens buys Osi Pharmaceuticals Inc., Elan Corp. Plc, Amylin Pharmaceuticals Inc., sells Biomet Inc., Bausch & Lomb Inc., Cvs Corp. during the 3-months ended 03/31/2007, according to the most recent filings of his investment company, Vanguard Health Care Fund. Edward Owens owns 81 stocks with a total value of $24.5 billion. These are the details of the buys and sells.
New Purchases: AMLN, ELN, OSIP,
Added Positions: SIAL, WAG,
Reduced Positions: BAY, GILD, HGSI, VMSI,
Sold Out: BMET, BOL, CVS,
Added: Walgreen Co. (WAG, Financial)
Edward Owens added to his holdings in Drug Retailers company Walgreen Co. by 500%. His purchase prices were between $44.08 and $47.69, with an estimated average price of $45.6. The impact to his portfolio due to this purchase was 0.93%. His holdings were 6,000,000 shares as of 03/31/2007. Shares of Walgreen Co. were traded at around $44.77.
Added: Sigma-aldrich Corp. (SIAL, Financial)
Edward Owens added to his holdings in Specialty Chemicals company Sigma-aldrich Corp. by 100%. His purchase prices were between $37.79 and $42.35, with an estimated average price of $39.8. The impact to his portfolio due to this purchase was 0.41%. His holdings were 4,800,000 shares as of 03/31/2007. Shares of Sigma-aldrich Corp. were traded at around $43.54.
New Purchase: Osi Pharmaceuticals Inc. (OSIP, Financial)
Edward Owens initiated holdings in Biotechnology company Osi Pharmaceuticals Inc.. His purchase prices were between $31.92 and $36.22, with an estimated average price of $33.8. The impact to his portfolio due to this purchase was 0.19%. His holdings were 1,404,529 shares as of 03/31/2007. Shares of Osi Pharmaceuticals Inc. were traded at around $37.72.
New Purchase: Elan Corp. Plc (ELN, Financial)
Edward Owens initiated holdings in Pharmaceuticals company Elan Corp. Plc. His purchase prices were between $12.35 and $14.81, with an estimated average price of $13.3. The impact to his portfolio due to this purchase was 0.1%. His holdings were 1,820,000 shares as of 03/31/2007. Shares of Elan Corp. Plc were traded at around $19.04.
New Purchase: Amylin Pharmaceuticals Inc. (AMLN, Financial)
Edward Owens initiated holdings in Biotechnology company Amylin Pharmaceuticals Inc.. His purchase prices were between $36.41 and $42.05, with an estimated average price of $38.8. The impact to his portfolio due to this purchase was 0.08%. His holdings were 500,000 shares as of 03/31/2007. Shares of Amylin Pharmaceuticals Inc. were traded at around $45.26.
Reduced: Bayer Ag (BAY, Financial)
Edward Owens reduced to his holdings in Commodity Chemicals company Bayer Ag by 22.24%. His sale prices were between $52.14 and $61.01, with an estimated average price of $56.7. The impact to his portfolio due to this sale was 1.27%. Edward Owens still held 5,944,656 shares as of 03/31/2007. Shares of Bayer Ag were traded at around $71.79.
Reduced: Gilead Sciences Inc. (GILD, Financial)
Edward Owens reduced to his holdings in Biotechnology company Gilead Sciences Inc. by 36.8%. His sale prices were between $62.73 and $75.04, with an estimated average price of $69.7. The impact to his portfolio due to this sale was 0.9%. Edward Owens still held 3,949,848 shares as of 03/31/2007. Shares of Gilead Sciences Inc. were traded at around $83.72.
Reduced: Ventana Medical Systems Inc. (VMSI, Financial)
Edward Owens reduced to his holdings in Medical Equipment company Ventana Medical Systems Inc. by 48.84%. His sale prices were between $39.4 and $42.31, with an estimated average price of $41. The impact to his portfolio due to this sale was 0.06%. Edward Owens still held 550,000 shares as of 03/31/2007. Shares of Ventana Medical Systems Inc. were traded at around $51.32.
Reduced: Human Genome Sciences Inc. (HGSI, Financial)
Edward Owens reduced to his holdings in Biotechnology company Human Genome Sciences Inc. by 40.26%. His sale prices were between $10.28 and $12.48, with an estimated average price of $11.4. The impact to his portfolio due to this sale was 0.03%. Edward Owens still held 1,038,500 shares as of 03/31/2007. Shares of Human Genome Sciences Inc. were traded at around $10.51.
Sold Out: Cvs Corp. (CVS, Financial)
Edward Owens sold out his holdings in Drug Retailers company Cvs Corp.. His sale prices were between $30.89 and $34.51, with an estimated average price of $32.7. The impact to his portfolio due to this sale was less than 0.01%. Shares of Cvs Corp. were traded at around $37.58.
Sold Out: Bausch & Lomb Inc. (BOL, Financial)
Edward Owens sold out his holdings in Medical Supplies company Bausch & Lomb Inc.. His sale prices were between $49.12 and $54.81, with an estimated average price of $52.3. The impact to his portfolio due to this sale was less than 0.01%. Shares of Bausch & Lomb Inc. were traded at around $66.47.
Sold Out: Biomet Inc. (BMET)
Edward Owens sold out his holdings in Medical Equipment company Biomet Inc.. His sale prices were between $41.59 and $42.42, with an estimated average price of $42.1. The impact to his portfolio due to this sale was less than 0.01%. Shares of Biomet Inc. were traded at around $43.55.
Edward Owens buys Osi Pharmaceuticals Inc., Elan Corp. Plc, Amylin Pharmaceuticals Inc., sells Biomet Inc., Bausch & Lomb Inc., Cvs Corp. during the 3-months ended 03/31/2007, according to the most recent filings of his investment company, Vanguard Health Care Fund. Edward Owens owns 81 stocks with a total value of $24.5 billion. These are the details of the buys and sells.
New Purchases: AMLN, ELN, OSIP,
Added Positions: SIAL, WAG,
Reduced Positions: BAY, GILD, HGSI, VMSI,
Sold Out: BMET, BOL, CVS,
Added: Walgreen Co. (WAG, Financial)
Edward Owens added to his holdings in Drug Retailers company Walgreen Co. by 500%. His purchase prices were between $44.08 and $47.69, with an estimated average price of $45.6. The impact to his portfolio due to this purchase was 0.93%. His holdings were 6,000,000 shares as of 03/31/2007. Shares of Walgreen Co. were traded at around $44.77.
Added: Sigma-aldrich Corp. (SIAL, Financial)
Edward Owens added to his holdings in Specialty Chemicals company Sigma-aldrich Corp. by 100%. His purchase prices were between $37.79 and $42.35, with an estimated average price of $39.8. The impact to his portfolio due to this purchase was 0.41%. His holdings were 4,800,000 shares as of 03/31/2007. Shares of Sigma-aldrich Corp. were traded at around $43.54.
New Purchase: Osi Pharmaceuticals Inc. (OSIP, Financial)
Edward Owens initiated holdings in Biotechnology company Osi Pharmaceuticals Inc.. His purchase prices were between $31.92 and $36.22, with an estimated average price of $33.8. The impact to his portfolio due to this purchase was 0.19%. His holdings were 1,404,529 shares as of 03/31/2007. Shares of Osi Pharmaceuticals Inc. were traded at around $37.72.
New Purchase: Elan Corp. Plc (ELN, Financial)
Edward Owens initiated holdings in Pharmaceuticals company Elan Corp. Plc. His purchase prices were between $12.35 and $14.81, with an estimated average price of $13.3. The impact to his portfolio due to this purchase was 0.1%. His holdings were 1,820,000 shares as of 03/31/2007. Shares of Elan Corp. Plc were traded at around $19.04.
New Purchase: Amylin Pharmaceuticals Inc. (AMLN, Financial)
Edward Owens initiated holdings in Biotechnology company Amylin Pharmaceuticals Inc.. His purchase prices were between $36.41 and $42.05, with an estimated average price of $38.8. The impact to his portfolio due to this purchase was 0.08%. His holdings were 500,000 shares as of 03/31/2007. Shares of Amylin Pharmaceuticals Inc. were traded at around $45.26.
Reduced: Bayer Ag (BAY, Financial)
Edward Owens reduced to his holdings in Commodity Chemicals company Bayer Ag by 22.24%. His sale prices were between $52.14 and $61.01, with an estimated average price of $56.7. The impact to his portfolio due to this sale was 1.27%. Edward Owens still held 5,944,656 shares as of 03/31/2007. Shares of Bayer Ag were traded at around $71.79.
Reduced: Gilead Sciences Inc. (GILD, Financial)
Edward Owens reduced to his holdings in Biotechnology company Gilead Sciences Inc. by 36.8%. His sale prices were between $62.73 and $75.04, with an estimated average price of $69.7. The impact to his portfolio due to this sale was 0.9%. Edward Owens still held 3,949,848 shares as of 03/31/2007. Shares of Gilead Sciences Inc. were traded at around $83.72.
Reduced: Ventana Medical Systems Inc. (VMSI, Financial)
Edward Owens reduced to his holdings in Medical Equipment company Ventana Medical Systems Inc. by 48.84%. His sale prices were between $39.4 and $42.31, with an estimated average price of $41. The impact to his portfolio due to this sale was 0.06%. Edward Owens still held 550,000 shares as of 03/31/2007. Shares of Ventana Medical Systems Inc. were traded at around $51.32.
Reduced: Human Genome Sciences Inc. (HGSI, Financial)
Edward Owens reduced to his holdings in Biotechnology company Human Genome Sciences Inc. by 40.26%. His sale prices were between $10.28 and $12.48, with an estimated average price of $11.4. The impact to his portfolio due to this sale was 0.03%. Edward Owens still held 1,038,500 shares as of 03/31/2007. Shares of Human Genome Sciences Inc. were traded at around $10.51.
Sold Out: Cvs Corp. (CVS, Financial)
Edward Owens sold out his holdings in Drug Retailers company Cvs Corp.. His sale prices were between $30.89 and $34.51, with an estimated average price of $32.7. The impact to his portfolio due to this sale was less than 0.01%. Shares of Cvs Corp. were traded at around $37.58.
Sold Out: Bausch & Lomb Inc. (BOL, Financial)
Edward Owens sold out his holdings in Medical Supplies company Bausch & Lomb Inc.. His sale prices were between $49.12 and $54.81, with an estimated average price of $52.3. The impact to his portfolio due to this sale was less than 0.01%. Shares of Bausch & Lomb Inc. were traded at around $66.47.
Sold Out: Biomet Inc. (BMET)
Edward Owens sold out his holdings in Medical Equipment company Biomet Inc.. His sale prices were between $41.59 and $42.42, with an estimated average price of $42.1. The impact to his portfolio due to this sale was less than 0.01%. Shares of Biomet Inc. were traded at around $43.55.
